Beyond the Pill: How Hospitals Are Rebuilding Care with Specialty Pharmacies

SCHAUMBURG, IL – August 13, 2026 – On a Thursday in suburban Chicago, Ann & Robert H. Lurie Children's Hospital of Chicago cut the ribbon on a 2,050-square-foot space that looks, at first glance, like a modern pharmacy. But the opening of this facility, located in the hospital's new Outpatient and Infusion Center, represents something far more significant than new shelving and counters. It marks the activation of a new system—a strategic overhaul of how one of the nation's top children's hospitals manages the most complex, costly, and critical aspect of modern pediatric medicine.

In partnership with Boston-based Clearway Health, Lurie Children's has launched its first-ever outpatient specialty pharmacy. The move is a direct response to a healthcare environment where groundbreaking treatments are often trapped behind a wall of administrative complexity and financial barriers. For the families of children with conditions like cystic fibrosis, cancer, or rare genetic disorders, this new facility is designed to be a gateway, not a gatekeeper.

“The opening of Lurie Children's first specialty pharmacy represents an important step forward in our commitment to delivering compassionate, expert care for children and their families,” said Tom Shanley, MD, president and CEO of Lurie Children's. He noted the goal is to make it “easier to access critical medications, reducing barriers to care and providing the personalized support families need.” But beneath the patient-centric mission lies a powerful business reality: this initiative is also about building “financial stability for Lurie Children's into the future.” This dual purpose—improving care while securing the bottom line—is the core of a systemic shift happening in hospitals across the country.

The Labyrinth of Modern Medicine

To understand the significance of this opening, one must first understand the labyrinth that families must navigate to obtain specialty medications. These are not the simple prescriptions one picks up at a local drugstore. They are high-cost, complex therapies that often require special handling, strict adherence protocols, and a dizzying amount of paperwork.

For years, the default process has been to outsource this function to large, external mail-order pharmacies. This system fragments care, creating a chasm between the prescribing doctor and the dispensing pharmacist. Families find themselves caught in the middle, battling insurance companies over prior authorizations, hunting for financial assistance to cover astronomical co-pays, and waiting weeks, sometimes months, for a critical medication to arrive. For a child whose health depends on the timely initiation of therapy, these delays are not just inconvenient; they can be detrimental.

Research and anecdotal evidence paint a grim picture of this fragmented system. The administrative burden falls heavily on caregivers, who must become expert project managers of their child's condition. It also falls on clinical staff, with nurses and doctors spending countless hours on the phone with insurers instead of focusing on patients. This is the friction that the in-house specialty pharmacy model is designed to eliminate.

A New Economic Engine for Healthcare

While the patient benefits are clear, the strategic decision to bring a specialty pharmacy in-house is also a powerful financial one. For decades, hospital pharmacies have been treated as cost centers. The in-house specialty model flips that paradigm, transforming the pharmacy into a significant revenue-generating engine.

This is where partners like Clearway Health come in. Born from the real-world experience of Boston Medical Center, which grew its own specialty pharmacy revenue by over $580 million in ten years, Clearway provides the blueprint and operational muscle for health systems to build their own programs. Their model isn't just about dispensing drugs; it's about building a sustainable asset.

By capturing the revenue from high-cost specialty drugs that was previously flowing to external entities, hospitals can dramatically improve their financial health. For a non-profit like Lurie Children's, which reported a loss from operations of nearly $45 million in 2024, creating new, reliable revenue streams is essential for long-term sustainability and reinvestment in care. Clearway Health's track record with other institutions illustrates the potential. At OU Health, a similar partnership generated over $288 million in revenue in two years. At another partner hospital, an on-site pharmacy contributed $31.7 million to revenue, far exceeding initial projections.

“Our collaboration with Lurie Children's brings together clinical expertise, operational experience and a shared commitment to advancing care for children with complex health needs,” said Brandon Newman, PharmD, CEO of Clearway Health. He emphasizes the work done “alongside the Lurie Children's team to design and build a specialty pharmacy program that enhances care coordination and creates meaningful benefits for patients, families, providers and care teams.”

Integrating Care, One Liaison at a Time

The true innovation of this system, however, lies not in the financial statements but in its operational design. The core of the model is the integration of skilled specialty pharmacy patient liaisons directly into the hospital's clinical practices. These liaisons are the human interface of the system, embedded in clinics for oncology, endocrinology, neurology, and more.

Their job is to proactively dismantle the barriers that delay care. When a doctor prescribes a specialty medication, the liaison is there to immediately begin the work of securing insurance approval, investigating benefits, and enrolling the family in financial assistance programs. Clearway Health's data shows this model can slash prior authorization turnaround times from weeks to just over a day. This is the machinery that unburdens both the family and the clinical team.

Beyond the paperwork, these experts provide personalized education, coordinate home delivery, and conduct follow-up assessments to monitor treatment and ensure adherence. For pediatric patients, where weight-based dosing and complex regimens are common, this high-touch support is critical. Studies have consistently shown that such integrated pharmacy models lead to significantly better medication adherence, which in turn improves health outcomes and reduces costly hospitalizations.

This is not just about convenience; it is about building a more resilient and effective system of care from the ground up. By embedding the solution directly within the patient's existing care team, the hospital ensures continuity and eliminates the dangerous gaps that form when care is fragmented. It’s a model that recognizes that for children with the most complex health needs, managing their medication is as vital as the diagnosis itself.